In short. Who injects, how the substance is prepared and at what depth, how lumps are handled if they appear, and what happens if the effect arrives unevenly.
Key points
- What would you do if a firm lump appeared six months after the course?
- The honest answer describes observation, the way massage is prescribed, what injected treatment can achieve, and when removal would be considered.
- A clinic that treats this substance should know what its own plan is before it places anything.
This substance cannot be dissolved, so the consultation before the first session is the point at which everything that can be controlled is decided. The questions worth asking are short, they are specific to this material rather than to injectables in general, and a practice that treats it regularly will have the answers ready.
About the person injecting
How often do they use this substance, and in which areas? Not injectables generally, but this material in the zone being treated. What is their reason for using it here rather than a reversible filler? How many sessions do they plan, how far apart, and what would make them stop the course early? A clinician who treats these areas regularly will have a settled view on all of it.
About how it will be handled
How is the substance prepared for the area being treated, and does that change for thinner or more mobile skin? How deep will it be placed, and what is the reason for that plane? How much is planned for the first session, and is that deliberately conservative? These are the decisions that determine whether the result is even, and they are all made before the needle is opened.
The question that should be answered first
What would you do if a firm lump appeared six months after the course? The honest answer describes observation, the way massage is prescribed, what injected treatment can achieve, and when removal would be considered. A clinic that treats this substance should know what its own plan is before it places anything.
About the plan and its end
How many sessions, across how many months, and what is the review for? When can the result honestly be judged, and what happens if the effect arrives unevenly across the treated area? What is the plan if the review at three months shows no visible change? A plan with no stated end and no stopping rule is being sold rather than planned, and the difference is visible in how easily the questions are answered.
Answers that should end the appointment
- Anyone describing the treatment as fully reversible, which is not true of this substance.
- Anyone who cannot describe how depth and spacing are decided for the area you are asking about.
- Anyone who cannot say what happens if a lump appears months later, or who answers only that it will not.
None of these questions requires medical knowledge to ask. All of them are answerable in a short conversation by a clinician who works with this material, and the answers are more informative than any before-and-after photograph, because they describe a process rather than an outcome someone else had. The record of what was placed, how it was prepared and when should also be kept, and it is reasonable to ask for it in writing after every session.
Frequently asked questions
Why does preparation matter more than which product is used?
Because the risk that decides this treatment is driven by how the material is handled, how deep it is placed and how much goes into one area. Those decisions are made in the room rather than on a label, and a well-handled material produced by a careful injector is a better proposition than a poorly handled one.
Should I ask how many of these the injector does?
Yes. Not because a number guarantees anything, but because the nodule risk depends on judgement that comes from repetition, and because a clinician who works in these areas regularly has a settled view on depth, spacing and how much to place. General filler experience does not transfer automatically.
What if the practice cannot answer these questions?
Then you have the most useful information an assessment can give you. None of these questions requires medical knowledge to ask, and all of them are answerable in a short conversation by anyone who treats this substance regularly. Vague answers are an answer.
Risks & Limitations
- Irreversibility: there is no dissolving agent for this substance. A lump, an asymmetry or an over-correction is managed over time, with injected treatment, or occasionally by removal, and never switched off.
- Nodules and granulomas — firm lumps or an inflammatory reaction that can appear weeks or months after treatment and may need assessment and treatment rather than simply resolving.
- Unevenness or over-correction. This substance is placed in an area that cannot be dissolved, so over-treatment is harder to correct than under-treatment.
- Firmness under the skin in the first weeks, which is expected and usually settles, but does not always.
- Infection or inflammation at an injection site, which needs prompt assessment rather than waiting.
- Bruising, swelling, tenderness and occasional headache after treatment.
- The volume visible on the day is the carrier rather than the effect. The result develops over months and cannot be judged early, it is not permanent, and the area continues to age.
When to Seek Care
- A firm, growing or painful lump at or near an injection site, appearing weeks or months after treatment — this needs assessment even when it is not painful.
- Redness, warmth, swelling or pus at an injection site, or fever.
- Skin breakdown, blistering, or a dusky or mottled patch over a treated area — seek care immediately.
- Increasing pain, or pain out of proportion to the injection.
- Difficulty breathing, facial swelling or a widespread rash — possible severe reaction; seek emergency care immediately.
References & Further Reading
- American Academy of Dermatology (AAD) — injectable and skin safety information
- American Society of Plastic Surgeons (ASPS) — injectable treatment guidance
- U.S. Food and Drug Administration (FDA) — approved injectable products and safety communications
- National Medical Products Administration (NMPA, China) — approved product status
- Chongqing West District Hospital — Plastic Surgery & Aesthetics Medical Center
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.